More recent studies suggest that LY6A+ RSCs can function as tumor-initiating stem cells during CRC development (12, 13), with evidence indicating that the activation of fetal-like gene signatures, including Ly6a, during tissue repair may initiate neoplastic transformation if sustained over time (14). The gene discussed is LY6S; the disease is colorectal carcinoma.